Female Mesothelioma Doctors Andrea Wolf and Hedy Lee Kindler

We would like to recognize two women in the mesothelioma community that have had a pivotal role in advancing the treatment for patients with malignant mesothelioma. We are witnessing history in the making as we recognize their accomplishments. Decades from now, future generations will be studying their lives’ work and accomplishments.

Dr. Andrea Wolf is an accomplished  surgeon and researcher. Dr. Wolf is the director of the Women’s Lung Cancer Center at Mount Sinai Hospital in New York. Her expertise is well developed in the thoracic surgical  world. Included in her practice is proficiency in robotic and minimally invasive techniques, which include video–assisted thoracic and laparoscopic surgeries for benign and malignant diseases of the chest, lung, mediastinum, diaphragm and esophagus. She developed a passion for mesothelioma while working alongside Dr. David Sugarbaker in Boston, Massachusetts. This passion has become one her focuses of her career. Her belief is that with her research and continued fight against this disease, a standard of care will be developed when providing care for mesothelioma patients. She has co-authored many research articles including one in the Annals of Thoracic Surgery in 2014 regarding the survival rate of women with malignant pleural mesothelioma. The article’s conclusion is that women are diagnosed with malignant pleural mesothelioma less frequently than men but have a longer survival time with the disease. 

Dr. Wolf attended Princeton University and then went on to Harvard Medical School. She also received a Masters of Public Health at Harvard University. Dr. Wolf did her residency at Massachusetts General Hospital and her fellowship at Brigham and Women’s Hospital .  

Dr. Hedy Lee Kindler is a medical expert in the field of oncology at the University of Chicago Comprehensive Cancer Center. Dr. Kindler is an internationally recognized researcher with many of her projects focusing on mesothelioma. Her research often focuses on novel agents such as immunotherapy medications used in the treatment of malignant mesothelioma. One of her many accomplishments is that she is a past president of the Mesothelioma Applied Research Foundation.

Dr. Kindler is a graduate of Yale University and the State University of New York. She did both her internship and residency at the University of California Los Angeles Health. Her fellowship was done at Memorial Sloan Kettering Cancer Center in New York City.

Both of these accomplished physicians are major contributors to the advancement of treatment for patients with malignant mesothelioma.